Story perspectives

Study Reveals GLP-1 Drugs Best for Diabetes Heart Health

10/16/2025

44 3

Summary

Story summary

A study by Kaiser Permanente assessed four glucose-lowering medications for adults with type 2 diabetes, focusing on heart attack and stroke risks.
Published in JAMA Network Open, the study involved nearly 300,000 participants and found that GLP-1 receptor agonists, especially liraglutide and semaglutide, offered the greatest cardiovascular protection.
SGLT2 inhibitors ranked second in effectiveness, while sulfonylureas and DPP4 inhibitors were less effective.
A separate study of 22,000 US veterans showed similar results for GLP-1 receptor agonists, indicating a need for further long-term research.

1 of 1

Story summary

A study by Kaiser Permanente assessed four glucose-lowering medications for adults with type 2 diabetes, focusing on heart attack and stroke risks.
Published in JAMA Network Open, the study involved nearly 300,000 participants and found that GLP-1 receptor agonists, especially liraglutide and semaglutide, offered the greatest cardiovascular protection.
SGLT2 inhibitors ranked second in effectiveness, while sulfonylureas and DPP4 inhibitors were less effective.
A separate study of 22,000 US veterans showed similar results for GLP-1 receptor agonists, indicating a need for further long-term research.